These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 27021022)

  • 1. Altered Long Noncoding RNA Expression Precedes the Course of Parkinson's Disease-a Preliminary Report.
    Kraus TFJ; Haider M; Spanner J; Steinmaurer M; Dietinger V; Kretzschmar HA
    Mol Neurobiol; 2017 May; 54(4):2869-2877. PubMed ID: 27021022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
    Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
    Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression signatures of long non-coding RNA in the substantia nigra of pre-symptomatic mouse model of Parkinson's disease.
    Jiao F; Wang Q; Zhang P; Bu L; Yan J; Tian B
    Behav Brain Res; 2017 Jul; 331():123-130. PubMed ID: 28476570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome sequencing in a 6-hydroxydopamine rat model of Parkinson's disease.
    Li J; Sun Y; Chen J
    Genes Genet Syst; 2019 Apr; 94(2):61-69. PubMed ID: 30713215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of long noncoding RNAs in early diabetic retinopathy.
    Yan B; Tao ZF; Li XM; Zhang H; Yao J; Jiang Q
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):941-51. PubMed ID: 24436191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key Non-coding Variants in Three Neuroapoptosis and Neuroinflammation-Related LncRNAs Are Protectively Associated with Susceptibility to Parkinson's Disease and Some of Its Clinical Features.
    Shadkam R; Saadat P; Azadmehr A; Chehrazi M; Daraei A
    Mol Neurobiol; 2024 May; 61(5):2854-2865. PubMed ID: 37946005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of exosomal lncRNA and mRNA expression profiles reveals the involvement of lnc-MKRN2-42:1 in the pathogenesis of Parkinson's disease.
    Wang Q; Han CL; Wang KL; Sui YP; Li ZB; Chen N; Fan SY; Shimabukuro M; Wang F; Meng FG
    CNS Neurosci Ther; 2020 May; 26(5):527-537. PubMed ID: 31814304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of non-coding RNAs in Parkinson's disease.
    Majidinia M; Mihanfar A; Rahbarghazi R; Nourazarian A; Bagca B; Avci ÇB
    Mol Biol Rep; 2016 Nov; 43(11):1193-1204. PubMed ID: 27492082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal dysregulation of long non-coding RNAs in Parkinson's disease.
    Müller-Nedebock AC; Cuttler K; Pfaff AL; Kõks S
    Exp Biol Med (Maywood); 2023 Oct; 248(20):1780-1784. PubMed ID: 37750041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
    Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
    Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of long noncoding RNAs in cartilage from knee osteoarthritis patients.
    Fu M; Huang G; Zhang Z; Liu J; Zhang Z; Huang Z; Yu B; Meng F
    Osteoarthritis Cartilage; 2015 Mar; 23(3):423-32. PubMed ID: 25524778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-asarone protects against MPTP-induced Parkinson's disease via regulating long non-coding RNA MALAT1 and inhibiting α-synuclein protein expression.
    Zhang QS; Wang ZH; Zhang JL; Duan YL; Li GF; Zheng DL
    Biomed Pharmacother; 2016 Oct; 83():153-159. PubMed ID: 27470562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray analysis of an synthetic α-synuclein induced cellular model reveals the expression profile of long non-coding RNA in Parkinson's disease.
    Lin D; Liang Y; Jing X; Chen Y; Lei M; Zeng Z; Zhou T; Wu X; Peng S; Zheng D; Huang K; Yang L; Xiao S; Liu J; Tao E
    Brain Res; 2018 Jan; 1678():384-396. PubMed ID: 29137975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA profiles of adrenocortical cancer can be used to predict recurrence.
    Glover AR; Zhao JT; Ip JC; Lee JC; Robinson BG; Gill AJ; Soon PS; Sidhu SB
    Endocr Relat Cancer; 2015 Feb; 22(1):99-109. PubMed ID: 25595289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
    Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
    Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed long noncoding RNAs in bladder cancer.
    Peter S; Borkowska E; Drayton RM; Rakhit CP; Noon A; Chen W; Catto JW
    Clin Cancer Res; 2014 Oct; 20(20):5311-21. PubMed ID: 25165097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.
    Sun C; Liu X; Yi Z; Xiao X; Yang M; Hu G; Liu H; Liao L; Huang F
    IUBMB Life; 2015 Nov; 67(11):847-52. PubMed ID: 26472541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lncRNA survey finds increases in neuroprotective LINC-PINT in Parkinson's disease substantia nigra.
    Simchovitz A; Hanan M; Yayon N; Lee S; Bennett ER; Greenberg DS; Kadener S; Soreq H
    Aging Cell; 2020 Mar; 19(3):e13115. PubMed ID: 32080970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.